Cannabis Law Report

JANUARY 30, 2019

To expand the number of manufacturers, the Drug Enforcement Administration (DEA) submitted a notice in the Federal Register on August 11, 2016, soliciting applications for licenses to manufacture marijuana for research purposes. The first letter was sent on May 13, 2015, and the second letter was sent on November 18, 2018. Hearing Tr.

Research and Development 63

Research and Development DEA CBD Law 63

Canna Law Blog

AUGUST 31, 2023

We haven’t yet seen the HHS letter so we’re not sure what changed from the last “medical and scientific” evaluation undertaken by the Food and Drug Administration (FDA) and HHS in 2015 , but hey, we’ll take it. In any case, the DEA Administrator reports to the AG (through the Deputy AG).

DEA 118

DEA Marijuana Banking Research and Development 118

Cannabis Law Report

MARCH 25, 2019

The Attorney General forwards the request to the Health and Human Services Secretary and requests a scientific and medical evaluation and recommendation, as specified by 23 USC 811(b-c). At the present time, state medical and recreational legalization have no impact on federal drug control laws.

Banking 45

Banking Law Marijuana State Laws 45